2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
2
Classical hematology
2
Sarcoma
1
Other hematologic neoplasm
1
Head & Neck
1
Conditions
Sarcoma
1568
Glioblastoma
512
Gliosarcoma
485
Osteosarcoma
458
Brain Neoplasms
344
Gastrointestinal Stromal Tumors
324
Central Nervous System Neoplasms
296
Neoplasms
291
Dendritic Cell Sarcoma, Interdigitating
286
Astrocytoma
275
Lymphoma
259
Bone Neoplasms
243
Breast Neoplasms
237
Sarcoma, Ewing
236
Glioma
236
Neuroblastoma
230
Rhabdomyosarcoma
226
Melanoma
224
Precursor Cell Lymphoblastic Leukemia-Lymphoma
218
Recurrence
216
Lymphoma, Non-Hodgkin
216
Burkitt Lymphoma
213
Oligodendroglioma
203
Ovarian Neoplasms
200
Lymphoma, Large B-Cell, Diffuse
187
Neoplasm Metastasis
186
Lymphoma, Follicular
172
Leukemia
164
Leukemia, Lymphocytic, Chronic, B-Cell
158
Hodgkin Disease
158
Interventions
Pregabalin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pain, Intractable
×
Sarcoma
×
Clear all
NCT00381095
2021-01-20
COPE
Pfizer
Phase 4
Terminated
152 enrolled
14 charts